| 柔红霉素预防后囊膜混浊的临床研究 |
| |
| 引用本文： | 彭莹,杜岱雪. 柔红霉素预防后囊膜混浊的临床研究[J]. 眼科新进展, 2001, 21(2): 100-102 |
| |
| 作者姓名： | 彭莹 杜岱雪 |
| |
| 作者单位： | 1. 421001 湖南省衡阳市,衡阳医学院第一附属医院眼科
2. 湖南省长沙市,湖南医科大学湘雅医院眼科 |
| |
| 摘 要： | 目的 观察柔红霉素预防后囊膜混浊的临床效果。方法 对62只患白内障眼行白内障囊外摘出术及白内障囊外摘出并后房型人工晶状体植入术,分为实验组和对照组,实验组28眼,术中前房灌注液加入柔红霉素(7.5mg
|
| 关 键 词： | 柔红霉素 白内障 后囊膜混景 并发症 预防 |
| 文章编号： | 1003-5141(2001)02-0100-03 |
| 修稿时间： | 2000-06-14 |
Clinical study onprevention of the posterior capsule opacification by daurorubicin |
| |
| PENG Ying,DU Dai Xue From the. Clinical study onprevention of the posterior capsule opacification by daurorubicin[J]. Recent Advances in Ophthalmology, 2001, 21(2): 100-102 |
| |
| Authors: | PENG Ying DU Dai Xue From the |
| |
| Affiliation: | PENG Ying,DU Dai Xue From the Department of Ophthalmology,the First Affiliated Hospital of Hengyang Medical College |
| |
| Abstract: | Objective To observe the clinical effect of Daurorubicin (DNR)preventing the posterior capsule opacification(PCO).Methods Sixty-two eyes with cataract were divided into the experimental group (28 eyes) and the control group (34 eyes). All the patients were performed the extracapsular cataract extraction(ECCE) with or without posterior chamber intraocular lens implant (PC-IOL). The infusing liquid with DNR(7.5mg.L-1) was infused into the anterior chamber in the experimental group operatively; The Ringer liquid was infused into the anterior chamber in the control. The PCO was observed postoperatively.Results The occurence rate of PCO in the experimental group was obviously lower than that in the control (P＜0.05). After three months postoperatively, the patients' mean visual acuity in the experimental group was 4.47±0.24 and that in the control group was 4.66±0.26(P＜0.05). Conclusion DNR can effectively prevent the PCO, and has a good clinical value. |
| |
| Keywords: | daurorubicin cataract posterior capsule opacification |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
